Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-11-10

Clinical Trial Update: Effects Of Food And Dose Regimen On The Antiviral Effects Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessed how food intake and dosing schedule influence the antiviral effects of maraviroc (UK-427,857) in HIV-infected patients; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Maraviroc (maraviroc)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV | Phase 2 | Status: COMPLETED